EP3471562A4 - Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders - Google Patents

Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders Download PDF

Info

Publication number
EP3471562A4
EP3471562A4 EP17812794.0A EP17812794A EP3471562A4 EP 3471562 A4 EP3471562 A4 EP 3471562A4 EP 17812794 A EP17812794 A EP 17812794A EP 3471562 A4 EP3471562 A4 EP 3471562A4
Authority
EP
European Patent Office
Prior art keywords
disorders
prevention
treatment
human milk
milk oligosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17812794.0A
Other languages
German (de)
French (fr)
Other versions
EP3471562A1 (en
Inventor
Louise Kristine VIGSNÆS
Bruce Mcconnell
Emma ELISON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycom AS
Original Assignee
Glycom AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/183,391 external-priority patent/US10835544B2/en
Priority claimed from US15/183,431 external-priority patent/US10987368B2/en
Priority claimed from US15/183,404 external-priority patent/US10881674B2/en
Application filed by Glycom AS filed Critical Glycom AS
Publication of EP3471562A1 publication Critical patent/EP3471562A1/en
Publication of EP3471562A4 publication Critical patent/EP3471562A4/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP17812794.0A 2016-06-15 2017-06-15 Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders Pending EP3471562A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15/183,391 US10835544B2 (en) 2014-12-08 2016-06-15 Synthetic composition for regulating satiety
US15/183,431 US10987368B2 (en) 2014-12-08 2016-06-15 Synthetic composition for preventing or treating CVD
US15/183,404 US10881674B2 (en) 2014-12-08 2016-06-15 Synthetic composition for treating metabolic disorders
PCT/DK2017/050198 WO2017215721A1 (en) 2016-06-15 2017-06-15 Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders

Publications (2)

Publication Number Publication Date
EP3471562A1 EP3471562A1 (en) 2019-04-24
EP3471562A4 true EP3471562A4 (en) 2020-07-29

Family

ID=60663363

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17812794.0A Pending EP3471562A4 (en) 2016-06-15 2017-06-15 Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders

Country Status (2)

Country Link
EP (1) EP3471562A4 (en)
WO (1) WO2017215721A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021094993A1 (en) * 2019-11-14 2021-05-20 Glycom A/S Synthetic composition for balancing the bile acid profile in the intestine
WO2021123253A1 (en) * 2019-12-19 2021-06-24 Basf Se Composition for the treatment of (pre)hyperglycemia and/or associated morbidities thereto
EP4096440B1 (en) * 2020-01-31 2024-04-03 N.V. Nutricia Nutritional composition for use in gut maturation
WO2021191251A1 (en) * 2020-03-25 2021-09-30 Frieslandcampina Nederland B.V. COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac
TW202233201A (en) * 2020-12-16 2022-09-01 荷蘭商弗里斯蘭康必奶荷蘭有限公司 Synthetic compositions comprising lnfp iii and lsta
CN114145353A (en) * 2021-11-30 2022-03-08 内蒙古伊利实业集团股份有限公司 Formula milk powder capable of improving intestinal microenvironment health and preparation method and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
EP1962617A2 (en) * 2005-12-23 2008-09-03 N.V. Nutricia Infant nutritional compositions for preventing obesity
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
RU2478309C2 (en) * 2007-12-21 2013-04-10 Н.В. Нютрисиа Sphingomyelin and indigestible carbohydrates usage for gut microbiota normalisation
WO2011119023A1 (en) * 2010-03-26 2011-09-29 N.V. Nutricia Low protein infant formula with increased essential amino acids
RU2604503C2 (en) * 2011-10-18 2016-12-10 Нестек С.А. Composition for use in increasing insulin sensitivity and/or reducing insulin resistance
US20160113952A1 (en) * 2013-05-22 2016-04-28 Glycom As Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
WO2016091265A1 (en) * 2014-12-08 2016-06-16 Glycom A/S Synthetic composition for treating metabolic disorders
EP3407892A1 (en) * 2016-01-26 2018-12-05 Nestec S.A. Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth
BR112018013538A2 (en) * 2016-01-26 2018-12-04 Nestec S.A. compositions comprising 2fl and lnnt for use in infants or young children to prevent obesity, or related comorbidities, in later stages of life.
WO2017129648A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
EP3407897A1 (en) * 2016-01-26 2018-12-05 Nestec S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
EP3471562A1 (en) 2019-04-24
WO2017215721A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
EP3675882A4 (en) Methods and compositions for treatment of microbiome-associated disorders
IL298689B1 (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
EP3448398A4 (en) Compositions and methods for treatment of skin disorders
EP3370748A4 (en) Therapeutic microbiota for the treatment and/or prevention of food allergy
PT3377637T (en) Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
EP3471562A4 (en) Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3405215A4 (en) Methods for the treatment of danon disease and other disorders of autophagy
ZA202002066B (en) Compositions and methods for the treatment of eye disorders
EP3558279A4 (en) Compositions and methods for the treatment of chronic pain
EP3277287B8 (en) Mixtures of human milk oligosaccharides comprising 3 '-o-sialyllactose
EP3352749A4 (en) Compounds and compositions for the treatment of ocular disorders
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
IL272097A (en) Compounds for the prevention and treatment of medical disorders and uses thereof
IL269400A (en) Drugs and compositions for the treatment of ocular disorders
EP3518951A4 (en) Compositions and methods for the treatment of orthopedic ailments
EP3506899A4 (en) Compositions and methods for the diagnosis and treatment of lymphatic system disorders
EP3452169A4 (en) Methods and formulations for treatment and/or prevention of blood-associated disorders
EP3856147A4 (en) Methods and probiotic compositions for the treatment of bone disorders
EP3261446A4 (en) Methods and compositions for the treatment or prevention of parkinson's disease
EP3846851A4 (en) Compositions and methods for the diagnosis and treatment of lymphatic system disorders
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
EP3568138A4 (en) Compositions and methods for the treatment of myelin related and inflammation related diseases or disorders
EP3668836A4 (en) Compositions for the treatment of dry eye and methods of use thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/702 20060101ALI20200123BHEP

Ipc: A61P 3/04 20060101ALN20200123BHEP

Ipc: A23L 33/125 20160101AFI20200123BHEP

Ipc: A61P 3/10 20060101ALN20200123BHEP

Ipc: A61P 9/10 20060101ALN20200123BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20200626

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/10 20060101ALN20200622BHEP

Ipc: A61P 3/04 20060101ALN20200622BHEP

Ipc: A61P 3/10 20060101ALN20200622BHEP

Ipc: A23L 33/125 20160101AFI20200622BHEP

Ipc: A61K 31/702 20060101ALI20200622BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230922

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN